US$ 28.25
fda statement bpc-157 compounding safety risks Here's a nice graphic on that you can hand out to patients who inquire about it. Thanks to Chris Centeno, M.D The Hidden Risks of BPC‑157:
Description
Disclaimer Statements regarding this product have not been evaluated by regulatory authorities

Recovery timelines vary considerably, but many patients report gradual improvement within several weeks of discontinuation
Frequently asked questions Can I use tirzepatide after the expiration date

I have been going there for quite a while and all staff are very knowledgeable and kind

That difference is relevant
